Mattila, N., Seppänen, H., Mustonen, H., Przybyla, B., Haglund, C., & Lassila, R. (2018). Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma. Clinical and applied thrombosis/hemostasis, 24(8), 1267-1275. https://doi.org/10.1177/1076029618779133
Chicago Style (17th ed.) CitationMattila, Nora, Hanna Seppänen, Harri Mustonen, Beata Przybyla, Caj Haglund, and Riitta Lassila. "Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma." Clinical and Applied Thrombosis/hemostasis 24, no. 8 (2018): 1267-1275. https://doi.org/10.1177/1076029618779133.
MLA (9th ed.) CitationMattila, Nora, et al. "Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma." Clinical and Applied Thrombosis/hemostasis, vol. 24, no. 8, 2018, pp. 1267-1275, https://doi.org/10.1177/1076029618779133.